These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

977 related items for PubMed ID: 26045314

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Diagnostic impact of 18F-FDG PET-CT evaluating solid pancreatic lesions versus endosonography, endoscopic retrograde cholangio-pancreatography with intraductal ultrasonography and abdominal ultrasound.
    Schick V, Franzius C, Beyna T, Oei ML, Schnekenburger J, Weckesser M, Domschke W, Schober O, Heindel W, Pohle T, Juergens KU.
    Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1775-85. PubMed ID: 18481063
    [Abstract] [Full Text] [Related]

  • 23. Does 18F-FDG PET/MRI reduce the number of indeterminate abdominal incidentalomas compared with 18F-FDG PET/CT?
    Schaarschmidt BM, Grueneisen J, Heusch P, Gomez B, Umutlu L, Ruhlmann V, Rosenbaum-Krumme S, Antoch G, Buchbender C.
    Nucl Med Commun; 2015 Jun; 36(6):588-95. PubMed ID: 25759944
    [Abstract] [Full Text] [Related]

  • 24. Solid splenic masses: evaluation with 18F-FDG PET/CT.
    Metser U, Miller E, Kessler A, Lerman H, Lievshitz G, Oren R, Even-Sapir E.
    J Nucl Med; 2005 Jan; 46(1):52-9. PubMed ID: 15632034
    [Abstract] [Full Text] [Related]

  • 25. Usefulness of 18F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primary pancreatic carcinoma: a meta-analysis.
    Tang S, Huang G, Liu J, Liu T, Treven L, Song S, Zhang C, Pan L, Zhang T.
    Eur J Radiol; 2011 Apr; 78(1):142-50. PubMed ID: 19854016
    [Abstract] [Full Text] [Related]

  • 26. Detection of occult primary tumors in patients with cervical metastases of unknown primary tumors: comparison of (18)F FDG PET/CT with contrast-enhanced CT or CT/MR imaging-prospective study.
    Lee JR, Kim JS, Roh JL, Lee JH, Baek JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Radiology; 2015 Mar; 274(3):764-71. PubMed ID: 25405771
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Evaluation of soft-tissue lesions with (18)F-FDG PET/CT: initial results of a prospective trial.
    Leal AL, Etchebehere M, Santos AO, Kalaf G, Pacheco EB, Amstalden EM, Etchebehere EC.
    Nucl Med Commun; 2014 Mar; 35(3):252-9. PubMed ID: 24300379
    [Abstract] [Full Text] [Related]

  • 29. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
    Guan ZW, Xu BX, Wang RM, Sun L, Tian JH.
    Hell J Nucl Med; 2013 Mar; 16(2):97-102. PubMed ID: 23687644
    [Abstract] [Full Text] [Related]

  • 30. 18F-FDG PET/CT qualitative and quantitative evaluation in neurofibromatosis type 1 patients for detection of malignant transformation: comparison of early to delayed imaging with and without liver activity normalization.
    Chirindel A, Chaudhry M, Blakeley JO, Wahl R.
    J Nucl Med; 2015 Mar; 56(3):379-85. PubMed ID: 25655626
    [Abstract] [Full Text] [Related]

  • 31. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
    Rauscher I, Eiber M, Fürst S, Souvatzoglou M, Nekolla SG, Ziegler SI, Rummeny EJ, Schwaiger M, Beer AJ.
    J Nucl Med; 2014 May; 55(5):724-9. PubMed ID: 24652827
    [Abstract] [Full Text] [Related]

  • 32. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.
    Delbeke D, Rose DM, Chapman WC, Pinson CW, Wright JK, Beauchamp RD, Shyr Y, Leach SD.
    J Nucl Med; 1999 Nov; 40(11):1784-91. PubMed ID: 10565771
    [Abstract] [Full Text] [Related]

  • 33. 18F-FDG positron emission tomography CT (FDG PET-CT) in the management of pancreatic cancer: initial experience in 12 patients.
    Saif MW, Cornfeld D, Modarresifar H, Ojha B.
    J Gastrointestin Liver Dis; 2008 Jun; 17(2):173-8. PubMed ID: 18568138
    [Abstract] [Full Text] [Related]

  • 34. Detection of recurrent pancreatic cancer: comparison of FDG-PET with CT/MRI.
    Ruf J, Lopez Hänninen E, Oettle H, Plotkin M, Pelzer U, Stroszczynski C, Felix R, Amthauer H.
    Pancreatology; 2005 Jun; 5(2-3):266-72. PubMed ID: 15855825
    [Abstract] [Full Text] [Related]

  • 35. The value of 18F-FDG positron emission tomography/computed tomography on the pre-operative staging and the management of patients with pancreatic carcinoma.
    Wang XY, Yang F, Jin C, Guan YH, Zhang HW, Fu DL.
    Hepatogastroenterology; 2014 Oct; 61(135):2102-9. PubMed ID: 25722999
    [Abstract] [Full Text] [Related]

  • 36. The usefulness of (18)F-FDG PET/MRI fusion image in diagnosing pancreatic tumor: comparison with (18)F-FDG PET/CT.
    Nagamachi S, Nishii R, Wakamatsu H, Mizutani Y, Kiyohara S, Fujita S, Futami S, Sakae T, Furukoji E, Tamura S, Arita H, Chijiiwa K, Kawai K.
    Ann Nucl Med; 2013 Jul; 27(6):554-63. PubMed ID: 23580090
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Comparison of F-18-FDG PET/CT findings between pancreatic solid pseudopapillary tumor and pancreatic ductal adenocarcinoma.
    Kim YI, Kim SK, Paeng JC, Lee HY.
    Eur J Radiol; 2014 Jan; 83(1):231-5. PubMed ID: 24290142
    [Abstract] [Full Text] [Related]

  • 40. Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer.
    Strobel K, Heinrich S, Bhure U, Soyka J, Veit-Haibach P, Pestalozzi BC, Clavien PA, Hany TF.
    J Nucl Med; 2008 Sep; 49(9):1408-13. PubMed ID: 18703604
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 49.